Source Feed: Global News - Canada
Author: Uday Rana
Publication Date: May 4, 2026 - 12:21
Stay informed
‘Hopeful milestone’: Health Canada approves 2nd drug to slow Alzheimer’s
May 4, 2026
This is the second disease-slowing drug for Alzheimer’s that has been approved in Canada, after Health Canada approved lecanemab, commercially known as Leqembi, in October 2025.
A complaint alleging voting irregularities during a tense Ontario Liberal nomination meeting in Scarborough has been dismissed by a party arbitration committee.
May 24, 2026 - 21:41 | | CBC News - Canada
May 24, 2026 - 21:20 | Jeff Gray | The Globe and Mail
May 24, 2026 - 20:59 | Laura Stone | The Globe and Mail



Comments
Be the first to comment